Showing results (61-70 of 137) with videos related to
Sort By:
Pageof 14
Cancers|March 10, 2022
Reduced Absolute Count of Monocytes in Patients Carrying Hematological Neoplasms and SARS-CoV2 InfectionAlessandra Romano, Claudio Cerchione, Concetta Conticello, et al.Frontiers in Oncology|May 31, 2021
Clinical Relevance of ABCB1, ABCG2, and ABCC2 Gene Polymorphisms in Chronic Myeloid Leukemia Patients Treated With NilotinibFederica Loscocco, Giuseppe Visani, Annamaria Ruzzo, et al.In Vivo (Athens, Greece)|September 1, 2019
Successful Management of a Pregnant Patient With Chronic Myeloid Leukemia Receiving Standard Dose ImatinibStefania Stella, Elena Tirró, Michele Massimino, et al.Journal of Hematology & Oncology|December 6, 2019
Next-generation sequencing for BCR-ABL1 kinase domain mutation testing in patients with chronic myeloid leukemia: a position paperSimona Soverini, Elisabetta Abruzzese, Monica Bocchia, et al.International Journal of Molecular Sciences|December 11, 2019
The Q-LAMP Method Represents a Valid and Rapid Alternative for the Detection of the <i>BCR-ABL1</i> Rearrangement in Philadelphia-Positive LeukemiasStefania Stella, Enrico Marco Gottardi, Valeria Favout, et al.Carcinogenesis|January 22, 2014
IRF5 is a target of BCR-ABL kinase activity and reduces CML cell proliferationMichele Massimino, Maria Letizia Consoli, Maria Mesuraca, et al.Diseases (Basel, Switzerland)|February 26, 2026
Long-Term Survival with Daratumumab, Lenalidomide and Dexamethasone in Transplant-Ineligible Newly Diagnosed Multiple Myeloma Patients-A Survey from Two Italian CentersVittorio Del Fabro, Lara Gullo, Giuliana Giunta, et al.Anticancer Research|July 3, 2019
Efficacy of Nilotinib in a CML Patient Expressing the Three-way Complex Variant Translocation t(2;9;22)Elena Tirrò, Michele Massimino, Stefania Stella, et al.Clinical Case Reports|July 20, 2023
A case of high-risk AML in a patient with advanced systemic mastocytosisManlio Fazio, Calogero Vetro, Uroš Markovic, et al.Frontiers in Oncology|March 6, 2019
Chk1 Inhibition Restores Inotuzumab Ozogamicin Citotoxicity in CD22-Positive Cells Expressing Mutant p53Elena Tirrò, Michele Massimino, Chiara Romano, et al.Pageof 14